CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome

Clinical trial NCT03929211 · WITHDRAWN

Trial details

NCT number: NCT03929211
Sponsor: Wake Forest University Health Sciences
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Progressive Disease

Start date: 2021-05-01
Primary completion: 2022-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.